<SEC-DOCUMENT>0001144204-18-057051.txt : 20181102
<SEC-HEADER>0001144204-18-057051.hdr.sgml : 20181102
<ACCEPTANCE-DATETIME>20181102162620
ACCESSION NUMBER:		0001144204-18-057051
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20181031
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20181102
DATE AS OF CHANGE:		20181102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVAVAX INC
		CENTRAL INDEX KEY:			0001000694
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				222816046
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26770
		FILM NUMBER:		181157380

	BUSINESS ADDRESS:	
		STREET 1:		20 FIRSTFIELD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
		BUSINESS PHONE:		240-268-2000

	MAIL ADDRESS:	
		STREET 1:		20 FIRSTFIELD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv506109_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>



<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C.&nbsp;20549 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;8-K </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION&nbsp;13 OR 15(d)
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date of Report (Date of earliest event
reported): October 31, 2018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOVAVAX, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant as specified
in charter) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 32%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"><B>Delaware</B></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><B>000-26770</B></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><B>22-2816046</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(State or Other Jurisdiction</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of Incorporation)&nbsp;</B></P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Commission File Number)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(I.R.S. Employer</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Identification No.)</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>20 Firstfield Road</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Gaithersburg, Maryland 20878</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of Principal Executive Offices,
including Zip Code) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(240) 268-2000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Registrant&rsquo;s telephone number,
including area code) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>(Former name or former
address, if changed since last report.) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #211D1E">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.75in; color: #211D1E">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: -3in"><FONT STYLE="font-size: 10pt; color: #211D1E">Emerging
growth company&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #211D1E">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; color: #211D1E">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-indent: -49.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.75in; text-align: left"><B>Item 5.02.</B></TD><TD STYLE="text-align: justify"><B>Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-indent: -49.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Appointment
of Director Rachel K. King</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On October
31, 2018, the Board of Directors (the &ldquo;Board&rdquo;) of Novavax, Inc. (the &ldquo;Company&rdquo;) appointed Rachel K.
King to fill an existing vacancy in the Company&rsquo;s Board. Ms. King will serve as a Class III director and her term will
expire at the Company&rsquo;s 2019 annual meeting of stockholders. The Board has not appointed Ms. King to any Board
committees at this time. As compensation for her service on the Board, Ms. King will receive an annual retainer of $40,000.
Ms. King was granted a stock option award of 160,000 shares of
Company common stock under the Company&rsquo;s Amended and Restated 2015 Stock Incentive Plan, as amended. There is no
arrangement or understanding between Ms. King and any other person pursuant to which Ms. King was selected as a director. The
Board has affirmatively determined that Ms. King is independent and has no material direct or indirect interest in a related
party transaction which requires disclosure. Ms. King and the Company have entered into an indemnification agreement (the
&ldquo;Indemnification Agreement&rdquo;) which will provide indemnification protection for Ms. King in connection with her
service as a director of the Company. The Indemnification Agreement is substantially similar to the form filed as Exhibit
10.19 to the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2009, filed on March 16, 2010 and
incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On November 1,
2018, the Company issued a press release announcing Ms. King&rsquo;s appointment to the Board. A copy of the press release is attached
as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated in this Item 5.02 by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.75in; text-align: left"><B>Item 9.01.</B></TD><TD STYLE="text-align: justify"><B>Financial Statements and Exhibits.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 9%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 89%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1000694/000114420410013614/v176992_ex10-19.htm" STYLE="-sec-extract: exhibit">10.1</A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1000694/000114420410013614/v176992_ex10-19.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt; background-color: white">Form of Indemnity Agreement, as of January 1, 2010 (incorporated by reference to Exhibit 10.19 to the</FONT> <FONT STYLE="font-size: 10pt">Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2009 (File No. 000-26770), filed on March 16, 2010).</FONT></A></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="tv506109_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1</A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="tv506109_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt; background-color: white">Press release, dated November 1, 2018, regarding the appointment of Rachel K. King to the Company&rsquo;s Board of Directors.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>NOVAVAX,&nbsp;INC.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ John A. Herrmann III&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>John A. Herrmann III </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:&nbsp;&nbsp;</TD>
    <TD>Senior Vice President, General Counsel and Corporate Secretary</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: November 2, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv506109_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 30.75pt; width: 198pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Novavax Appoints Rachel King to Board
of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Gaithersburg,
MD, November 1, 2018</B> &ndash; Novavax, Inc., (Nasdaq: NVAX) today announced the appointment of Rachel King, Co-Founder and Chief
Executive Officer of GlycoMimetics, Inc., to its Board of Directors. In addition to extensive experience as an executive in the
biotechnology industry, Mrs. King has also worked in the venture capital side of life sciences, and has held executive positions
within a global multinational pharmaceutical company. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">&ldquo;We
are thrilled to welcome Rachel to our Board,&rdquo; said Stanley C. Erck, President and Chief Executive Officer of Novavax. &ldquo;Her
broad experience with late-stage assets will undoubtedly be valuable as we prepare for clinical data readouts in the first quarter
of 2019 from our two lead programs, ResVax&trade; and NanoFlu&trade;.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Before
founding GlycoMimetics, Inc. in 2003, Mrs. King was an Executive in Residence at New Enterprise Associates (NEA), one of the nation&rsquo;s
leading venture capital firms. Mrs. King joined NEA after serving as a Senior Vice President of Novartis Corporation. Before Novartis,
Mrs. King spent ten years with Genetic Therapy, Inc. (GTI) through the company&rsquo;s early stage, initial public offering, and
eventual sale to Novartis, after which she ran GTI as a wholly owned subsidiary of Novartis. Mrs. King worked previously at ALZA
Corporation and Bain and Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">&ldquo;I
am excited to join the Novavax Board,&rdquo; said Mrs. King. &ldquo;I look forward to contributing to the company&rsquo;s efforts
of advancing these important vaccines as they approach potential licensure.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Mrs.
King currently serves on the executive committee of the Biotechnology Innovation Organization (BIO). She also sits on the Board
of Directors of the University of Maryland BioPark. Mrs. King received her Bachelors of Arts degree from Dartmouth College and
her Masters in Business Administration from Harvard Business School. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>About Novavax</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Novavax,
Inc. (Nasdaq:</FONT><FONT STYLE="background-color: white">NVAX</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">)
is a late-stage biotechnology company that drives improved health globally through the discovery, development, and commercialization
of innovative vaccines to prevent serious infectious diseases. ResVax&trade;, its RSV vaccine for infants via maternal immunization,
is the only vaccine in a Phase 3 clinical program and is designed to prevent the second leading cause of death in children under
one year of age worldwide. Novavax is also advancing NanoFlu&trade;, its quadrivalent influenza nanoparticle vaccine, to address
key factors that can lead to the poor effectiveness of currently approved flu vaccines. Novavax is a leading innovator of recombinant
vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce
a new class of highly immunogenic nanoparticles addressing urgent global health needs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">For
more information, visit www.novavax.com and connect with us on Twitter and LinkedIn.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contacts: &#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Investors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Novavax, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Erika Trahan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Blue"><U>ir@novavax.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">240-268-2000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Westwicke Partners</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John Woolford</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Blue"><U>john.woolford@westwicke.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">443-213-0506</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Media</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sam Brown</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mike Beyer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Blue"><U>mikebeyer@sambrown.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">312-961-2502</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !> ET# 2(  A$! Q$!_\0
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MZ\_(.F":_/G_ (*/_P#!3KQE^W_\0)XYY;C1? .GSL=)T&.3"8'2:?&/,E.
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M_1-JWEH?6W@S_@KI^UG\1?%NFZ#H?Q'UG4]8UBY2TL[6#2K)Y)Y7.%4#R?\
MZPZFOW0_8P^''Q"^'7P,TB'XI>+IO&7C:Z076I7)BBCAM'=0?L\0C1 53IN(
MRQR>. /C?_@AW_P2I_X9W\(V_P 5O'VFC_A.M=M]VEV,Z?-H-JX/+#_GO(",
M\911M'):OT@080?2OR_BK,L)5J_5L%3C&,7JTDKOY=$?I'#6!Q5.E]8Q<Y.4
MMDVW9?YL=1117R)]0?R/T448S7],'\[E[6?#.H>'8-/EOK.:VBU2U6]LW=<+
M<0EF4.I[C<CK]5-4:_4;Q%^P0?VKO^"'7PO\7^'['SO&WP_T^^NX%C7]YJ%E
M]KF:>W)QDE0N]!ZA@/O&ORY'0=_>O-RS,Z>+YTM)0DXM=K?Y[GI9EET\*X/>
M,HJ2\[I7^X^X?^"&O[?1_90_:.7PCXBO?*\"_$"9+6=I'Q'IU]TAN#Z!N(V/
M'!4GA:_?N*?S>E?R1]#GOZU_0#_P0_\ V_/^&O?V;UT'Q!>>=XY\!QI9:@TC
MDR7]MT@NN>22!L8_WD)_B%?!<<9):V8TEV4OT?Z,^TX-S>Z> J/:[C^J_P C
M[=D_U;?0U_.C_P %O_\ E)W\2O\ >L?_ $BAK^BYFWPDCT-?SH_\%O\ _E)W
M\2O]ZQ_](H:X/#__ 'Z7^!_FCOXX_P!Q7^)?DSY/K]<O^#7C_CQ^+_\ UTTS
M^5Q7Y&U^N7_!KQ_QX_%__KIIG\KBOM^,?^135^7_ *4CX[A+_D9T_G^1^MDC
M[!TSGBOQE_X.0/VT[CQ-\3])^"VBWCKIN@1QZKKZ1O\ +/=2*&@B;'4)&V_'
MK(OH*_9:[=4AW-PJG.?2OY:_VO/BS-\=?VHO'WBZXD:1M<URZGC9CG]T)"D0
M^@C5 /8"OA>!LOC6QTJ\]J:37J]ONU9]IQICIT<&J,-YNS]$KO[]CSF@FBM#
MPAX7N/&_BW2=%LUWW>KWL-E OJ\CJB_JPK]?E)1BY2VW/RF$7*2BM]#[;_X)
M"?\ !(F;]N&ZD\<>-FOM-^&NFSF"**$F.?7)UP616ZI$N0&<9)(*C!!(_<#X
M.?L[>"?V??"\.C>#/#.B^'-/A4*([&T6(O[NP^9V/]YB2?6F_LZ_!32?V>_@
MEX7\%Z/;PQ6/AO3XK%"J >8R* SG_:9LL3W))KMZ_!\]SROC\1)MVIK2*Z6\
M_,_:\ER>C@J$4E>?675O_(C%O@?>_2J>M>&+'Q'I\EIJ%K:WMK,I22&>%9(Y
M >H*MD'\JT**\&.CNCVWKN?FC_P5!_X(3^%?BCX2U;QM\']+M_#7C*QC:YFT
M2S01:?K0'+*D?"PRXR05&UB "!G(_%&YMI+*ZE@FCDAF@<QR1R*5>-@<%2#R
M"#D$>U?ULRIF-OES[8ZU_/=_P7@_9OM_V>_V^=6NM/@CM],\>6,?B*-(U"HD
MSN\4X [9DB+_ /;2OU#@G/JU6H\#B'S:7BWOINOU1^<\89)2IP6-H*VMI)=;
M]?\ /N?&=>Q?L&_M8:I^Q=^U!X9\<6$DGV&UN4M]8M@V%O+!V G0^X7YE]&5
M37CM&,U^AXBC"O3E2J*ZDFGZ'P.'K2HU(U:6\7=']:'A?Q#:^+- L]4L9(Y[
M'4;>.ZMY4.5DC=0RL/8@@_C7S1_P6&_9(_X:V_8@\4:?8V_G^)/#B#7-% 7+
M&:'EXQ_UTB\Q/J5/:JW_  1+^+TWQB_X)P?#^ZNI&FO-%@ET29F.2?LTK1I_
MY#"5]67,:RP,K+N5NH/>OY\ESY?CKQ^*G+\G^I^Z1]GCL'K\-2/YH_DCSG_Z
MXZ45],?\%<?V4O\ AD7]MWQ/H]K;_9] \1.=>T4*N$6WG=B8QV_=R+(@'HJU
M\SU^_P"$Q5/$T8UZ>TE=?,_#\7AYX>O.A/>+L?J3_P &SW[2W]A?$KQI\*;Z
MXVP:Y"FNZ6C'I/%B.=5]V0QM_P!LS7[+@YK^6K]C;X^W7[+O[4?@?QW;NRQ^
M']6AFNU'_+6U9@DZ?\"B+CZD5_4-X:UNW\1Z+:W]I()K2^@CN() <B1'7<I'
MU!!K\FXZR_V..6(6U1?BK)_A9GZ=P7CO:X-T'O!V^3U_#8OT$X%%>3_MN_M%
MV_[*7[+OC3QY,R>9H.G,]HC=)KER$A3\9&4?3-?&TJ4ZM14X;MV7JSZZI4C3
M@YS=DM3\/?\ @N9^T[_PT1^W?K>GV=SY^A^ 8QH%GM;*-*AW7#CZRL5_[9BO
MCFIM4U.YUO5+B]O)I+J\O)7GGFD;<\LCL69B>Y).34)Z5_1&!PL<+A84(;12
M_P""?@^.Q<L3B9UI_:?X=#ZB_P""/W[)Q_:S_;@\,V%Y:FX\.^%V_M[5\KE#
M'"08XF_ZZ2[%P>J[J_H\B0)&H48  %?GY_P;Q_LF+\%/V2+CQQJ5KY>N?$J9
M+M3(O[R*PB+K;KG_ &MSR>X=?2OT%' K\=XPS/ZUF$H0^"&B_7\?R/U;A/+W
MAL#%S^*>K_1?<%>"_P#!1_\ :_M?V*_V3O$GC.1H?[6\O[#HD+M_Q\WTJD1#
M'HN"Y_V4->\EMM?@K_P7Y_;5_P"&B/VH5\!Z-=^=X5^&^ZV?8V8[K46_UTGH
M?+&(P>Q#^M<?#F4O'XV-.2]V.LO1=/GL=F?YHL#@Y55\3TCZO_+<^$M8UNZ\
M2ZO=ZC?7$MU?7\SW%Q/*Q9YI'8LS$GJ2Q)_&H8HVGF6-%9Y)#A549+'H *;]
MXU]=_P#!%/\ 8]_X:Q_;2TF?4+7[1X6\"[-<U4,NZ.5T8_9X3G@[Y1D@]5C:
MOV['8JEA,/.O/X8J_P#DOGLC\<P.%J8JO&A'>3_X=_J?1O[1_P#P2!7X<?\
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M?\&O'_'C\7_^NFF?RN*^>XQ_Y%-7Y?\ I2/>X2_Y&=/Y_D?K5.,IQZU_.O\
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MG%D_-CC<Q9B.]>/YK]+X9X9_LV#J56G4EIIT7;_,_/>(^(?[0DJ=)-0B^N[
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M'Q'_ ,%,?^",OA/]N43^)]!EM_"/Q'2+:-0"?Z+JN  JW2 9R ,"1?F&>0P
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M?"0H8F,G*.EU9Z=-VNFA^?YMP?5Q&+E5H245+6SOOUV/YSLXI"P_7%?T9_\
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MX$^V"BBB@!K('&"-WUK\5_\ @Y$_8^'@/XQZ+\7M'M@NG^,%73=:*+A8[V%
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MX9_;9^!6D^-O#4VU;I!#J%D[ S:;=!1YD#C/4$\'HP((ZU_+[7TE_P $Q_\
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8RDMK^?KW/T#A'/7;ZEB&VEL^OI_D?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
